Drug Eluting Balloon Catheter Market Outlook with Ongoing Trends, Top Players Profile Analysis and Forecast 2017-2022

Considering the widespread prevalence of vascular ailment, companies are emphasizing on developing low-cost and more efficient catheter technology. This Fact.MR report analyzes the expansion of global drug eluting balloon catheter market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of Fact.MR’s report is to analyze the global drug eluting balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global drug eluting balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to medical devices.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Key Insights From the Report Include:

1. Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness a robust growth over the next couple of years.

2. By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, coronary artery disease indication segment will command for more than two-third revenue share of the global market.

3. Hospitals will remain the largest end user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently commands for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.

4. By raw material, demand nylon based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards to the end of 2022, more than US$ 244 Mn worth nylon drug eluting balloon catheters are expected to be sold worldwide.

Browse Full Report with TOC- https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive

Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.

By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.

Competition Tracking

Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=146

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.